When CDH1 mutations were present, 91% of breast carcinomas lacked E-cadherin expression, and the remaining 9% with CDH1 mutations maintained E-cadherin expression, all involving missense mutations [48]. This evidence concerns the gene CDH1 and breast carcinoma.